Smartfit board member lifts stake by R$ 2,028 after offsetting on-market sell, buy
Bitget2026/10/09 21:42Smartfit disclosed open-market trades by its board during the month. Board members sold 11,992 common shares at an average price of 16.95742; total volume R$ 203,353. Board members bought 12,000 common shares at an average price of 17.11517; total volume R$ 205,382. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smartfit Escola de Ginástica e Dança SA published the original content used to generate this news brief on October 09, 2026, and is solely responsible for the information contained therein.
- Smartfit disclosed open-market trades by its board during the month.
- Board members sold 11,992 common shares at an average price of 16.95742; total volume R$ 203,353.
- Board members bought 12,000 common shares at an average price of 17.11517; total volume R$ 205,382.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
